IDEXX Laboratories, Inc.
IDXX
$491.70
$1.720.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.01% | 11.12% | 9.71% | -9.34% | 10.06% |
| Total Depreciation and Amortization | 13.91% | 13.35% | 17.76% | 15.57% | 5.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.91% | 228.80% | -30.91% | -118.43% | 19.63% |
| Change in Net Operating Assets | 25.46% | -120.89% | -457.25% | 123.92% | -15.31% |
| Cash from Operations | 19.83% | 4.87% | -19.22% | 23.96% | 7.98% |
| Capital Expenditure | 0.82% | 10.14% | 17.61% | -21.24% | 23.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.44% | -599.20% | -93.37% | -- | -- |
| Cash from Investing | 72.31% | -30.91% | 1.69% | -19.79% | -170.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -513.75% | -- | -- |
| Issuance of Common Stock | -65.55% | 16.99% | -60.41% | -47.89% | 63.17% |
| Repurchase of Common Stock | -146.75% | -566.44% | -525.97% | -272,811.39% | -1,618.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -129.27% | -128.57% | -576.10% | -39.20% | 1.37% |
| Foreign Exchange rate Adjustments | 42.77% | -309.48% | 296.89% | -197.06% | -911.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.00% | -116.66% | -146.74% | -80.64% | -4,692.11% |